Sacral tumors are relatively rare lesions, comprising 1%-7% of all spinal tumors.
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(WBB) systems. In the Enneking surgical staging system, tumors are classified by their biological aggressiveness, anatomical extent, and the presence or absence of metastatic disease. This classification has prognostic value and guides the choice of surgical margins-hence the goals of surgery-in primary tumors of the musculoskeletal system. It is, however, limited when applied to the spine and sacrum, as it does not take into account the complexities associated with spinal tumors such as the risk of neurological injury, stability, and the need for reconstruction. 3 Unlike the Enneking system, the WBB system is specifically designed for spinal tumors. It therefore attempts to take into account the particular anatomical considerations of the spine and spinal cord. It also offers guidelines to the feasibility and methods of resection. The primary concept of this system is to spare the spinal cord while not compromising the surgical tumor margins. However, it also does not account for the particular nuances of the sacral anatomy and the fact that the neural elements involved are below the level of the spinal cord and include the exiting sacral nerve roots as well as intrapelvic autonomic connections.
More recently, Klimo et al. 9 proposed a system specifically for nerve sheath tumors of the sacrum. This relatively simple system classifies tumors into 3 types based on their anatomical location (Type I, confined to the sacrum; II, extension through the anterior and posterior walls into the presacral and subcutaneous spaces; and III, located primarily in the presacral space). Each type corresponds to a particular surgical approach: Type I is posterior, III is anterior, and II is combined anterior-posterior. Wei and colleagues 10 modified the Klimo classification to include 4 tumor types: Type I, tumors confined to the intrasacral canal; II, those with extension through the intervertebral foramina into the presacral space; III, those with extension both anteriorly and posteriorly; and Type IV, those confined to the presacral space. This classification system also informed the surgical approaches used to address these lesions. Below the level of S-1, lesions of Types I, II, and III can be resected via a posterior approach whereas above S-1, Type II and III lesions require a combined approach. Type IV lesions can generally be resected via an anterior approach.
While all of the aforementioned systems do have clinical utility, none provide prognostic information or guide the use of adjuvant therapy, and, hence, they do not completely satisfy the criteria for an ideal surgical classification scheme. Moreover, the most commonly used systems, the WBB and Enneking models, are not specifically designed for the sacrum. In their study, Zhang and colleagues have proposed a new surgical classification method for sacral tumors. Their aim was to provide an improved system to guide surgical decision making, particularly related to the approaches used, for this relatively rare entity.
The classification of sacral tumors proposed by Zhang and colleagues 11 was based on a retrospective review of 92 surgically treated sacral tumors in patients who were treated during a 5-year period at a single institution. This was a heterogeneous group of tumors and the surgical approaches used were also varied. The resultant classification divides sacral tumors into 2 major types based on the sagittal plane anatomy (above or below S-2) Editorial See the corresponding article in this issue, pp 651-658. and then 4 further subtypes based on the extent of tumor in the pelvic cavity (< 5 cm or ≥ 5 cm). A further subdivision is then added according to the cross-sectional plane anatomy (3 zones: anterior sacrum, posterior sacrum, and lateral sacrum involving the sacroiliac joints). In summary, this classification thus proposes 16 possible categories of sacral tumor.
While the classification of sacral tumors proposed by Zhang and colleagues is novel and potentially interesting, there are a number of limitations that need to be recognized. The classification is based on an uncontrolled retrospective series consisting of a relatively small number of diverse tumor types, each with its own specific biology. Hence, it is difficult to draw strong conclusions on which predictive generalizations can be made. Furthermore, factors that can be critical in surgical planning and determining the specific goals of surgery such as tumor size, involvement of other organs, and distant metastases, were not considered. Moreover, the number of tumor subtypes (16 overall) makes the system difficult to apply in everyday clinical practice. Finally, the authors have not provided compelling evidence that their classification informs the choice of surgical approach.
There are however, several positive aspects of this newly proposed classification of sacral tumors. The simple stratification methods by which the tumors are classified make it logical to use and hence would likely have good inter-and intraobserver reliability, although this clearly requires formal confirmation. This has the obvious appeal of facilitating communication between surgeons and other clinicians and standardizing the language used to describe these lesions. Although the Zhang classification of sacral tumors is only based on a relatively small, retrospective case series, it does appear to largely corroborate the findings of Wei et al. 10 with respect to the surgical approaches used based on the location of the tumors. This lends credence to the validity of the model and suggests that it might be worthwhile to further test this in a prospective, multicenter manner. The study by Zhang and colleagues also highlights the need for an improved method of classifying and managing sacral tumors.
In conclusion, Zhang and colleagues should be commended for proposing a system that manages to logically and comprehensively classify tumors of the sacrum. In the future, prospective validation of this classification system will be required with the prospective application in a multicenter fashion and with the clear documentation of validated outcomes data and the assessment of impact on surgical approach used. It is clear that a validated system of classifying sacral tumors would greatly benefit the management of these complex entities.
